Newer anti-vascular endothelial growth factor agents

TNOA Journal of Ophthalmic Science and Research

卷:58

关键词: abicipor pegol;    anti-vascular endothelial growth factor;    brolucizumab;    conbercept;    faricimab;   

DOI  :  10.4103/tjosr.tjosr_98_20

来源: DOAJ

【 摘 要 】

Ocular angiogenesis is a major cause of ocular morbidity worldwide. Vascular endothelial growth factor (VEGF) is a critical regulator of angiogenesis and vascular permeability with diverse roles both during the development and adulthood. This is believed to be the most powerful mediator of angiogenesis leading to ischemia-induced neovascularization in the retinal and choroidal diseases. Anti-VEGF has revolutionized the treatment of such angiogenic and exudative diseases of the retina and choroid. This article gives a brief view of the newer anti-VEGF agents and their role in retinal diseases.

【 授权许可】

Unknown